Literature DB >> 22417262

SF3B1 in chronic lymphocytic leukemia.

Jinichi Mori, Yukie Takahashi, Tetsuya Tanimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22417262     DOI： 10.1056/NEJMc1201040

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms.

Authors:  Mario Cazzola; Marianna Rossi; Luca Malcovati
Journal:  Blood       Date:  2012-11-16       Impact factor: 22.113

Review 2.  The genomic landscape of chronic lymphocytic leukemia: clinical implications.

Authors:  Víctor Quesada; Andrew J Ramsay; David Rodríguez; Xose S Puente; Elías Campo; Carlos López-Otín
Journal:  BMC Med       Date:  2013-05-09       Impact factor: 8.775

3.  Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1).

Authors:  Felicia Fei-Lei Chung; Perry Faith Tze Ming Tan; Vijay Joseph Raja; Boon-Shing Tan; Kuan-Hon Lim; Toh-Seok Kam; Ling-Wei Hii; Si Hoey Tan; Sze-Jia See; Yuen-Fen Tan; Li-Zhe Wong; Wai Keat Yam; Chun Wai Mai; Tracey D Bradshaw; Chee-Onn Leong
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

4.  Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia.

Authors:  M Schwaederlé; E Ghia; L Z Rassenti; M Obara; M L Dell'Aquila; J F Fecteau; T J Kipps
Journal:  Leukemia       Date:  2013-01-22       Impact factor: 11.528

Review 5.  Getting personalized cancer genome analysis into the clinic: the challenges in bioinformatics.

Authors:  Alfonso Valencia; Manuel Hidalgo
Journal:  Genome Med       Date:  2012-07-30       Impact factor: 11.117

6.  SF3B1 mutation is a prognostic factor in chronic lymphocytic leukemia: a meta-analysis.

Authors:  Zhenghao Zhang; Shu Chen; Shuang Chen; Gang Chen; Rui Zhang; Jinhua Li; Jianhua Qu
Journal:  Oncotarget       Date:  2017-07-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.